SPY343.38+1.37 0.40%
DIA282.95+0.92 0.33%
IXIC11,516.49+37.51 0.33%

Wells Fargo Initiates Coverage On Intellia Therapeutics with Overweight Rating

Wells Fargo initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Overweight rating.

· 10/14/2020 06:59
Wells Fargo initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Overweight rating.